A case of moderate hypertriglyceridemia with apolipoprotein E phenotype E4/3

Tokai Journal of Experimental and Clinical Medicine

Volumn 21, Issue 4-6, 1996, Pages 165-169

  Kojima, Seiichiro ^a   Homma, Yasuhiko ^b   Sakane, Hiroya ^b   Kobayashi, Toshio ^b   Ozawa, Hideki ^b   Okajima, Yoshiaki ^a  

^a TOKAI UNIVERSITY   (Japan)

^b TOKAI UNIVERSITY OISO HOSPITAL   (Japan)

Author keywords

ApoE phenotype; Apolipoproteins; Hyperinsulinism; Hypertriglyceridemia; Remnant like particle

Indexed keywords

APOLIPOPROTEIN E; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOPROTEIN; LIPID; LIPOPROTEIN;

ADULT; ARTICLE; BLOOD; CASE REPORT; GENETICS; HUMAN; HYPERTRIGLYCERIDEMIA; MALE; PHENOTYPE;

ADULT; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; APOLIPOPROTEINS E; APOPROTEINS; HUMANS; HYPERTRIGLYCERIDEMIA; LIPIDS; LIPOPROTEINS; MALE; PHENOTYPE;

EID: 0030320349     PISSN: 03850005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Aalto-Setäla K, Fisher WA, Chen X, Chadek-Shaul T, Hayek T, Zechner R, Walsh A, Ramakrishnam R, Ginsberg HN, and Breslow JL: Mechanism of hypertriglyceridetnia in human apolipoprotein (apo) CIII transgenic mice. Diminished very low density lipoprotein fractional catabolic rate associated with increased apoCIII and reduced apoE on the particles. J. Clin. Invest., 90 : 1889-1900, 1993
2. Albers JJ, Tollefson JH, Chen C-H, and Steinmetz A: Isolation and characterization of human lipid transfer proteins. Arteriosclerosis, 9 : 49-58, 1984
3. Appelbaum-Bowden W: Lipase and lecithin:cholesterol acyltransferase in the control of lipoprotein metabolism., Current Opinion Lipidol, 6 : 130-135, 1995
4. Auwerx JH, Marzetta CA, Hokanson TE, and Brunzell JD: Large buoyant LDL-like particles in hepatic lipase deficiency. Arteriosclerosis, 9 : 319-325, 1989
5. Brown WV: Lipoprotein disorders in diabetes mellitus. Med. Clin. North America, 78 : 143-161, 1994
6. Burstein M, Scholnick HR, and Morfin R: Rapid method for isolation of lipoprotein from human plasma J. Lipid Res., 11 : 583-595, 1970
7. Fielding CJ, and Fielding PE: Molecular physiology of reverse cholesterol transport. J. Lipid Res., 36: 211-228, 1991
8. Goldberg IJ, Paferniti LN-A, Ginsberg HN, Lindgren FT, and Brown FT. Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J. Clin. Invest., 70 : 1184-1192, 1982
9. Havel RJ and KaneJP. Introduction: structure and metabolism of plasma lipoproteins. In the Metabolic and Molecular Bases of Inherited Disease (eds: Scriver CR, Beaudet AL, Sly WS, and Valle D). New York, McGraw-Hill, 1995, 1841-1851 pp.
10. Havel RJ, Eder HA, and Bragdon JH: The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest., 34: 1545-1553, 1955
11. Homma Y, Nakaya N, Nakamura H, and Goto Y: Increase in the density of lighter low density lipoprotein by hepatic triglyceride lipase. Artery: 13, 19-31, 1985
12. Homma Y, Kobayashi T, Yamaguchi H, Sakane H, Ozawa H, Matsuda M, Mikami Y, Mikami Y, and Nakamura H: Decrease of plasma large, light LDL (LDL1), HDL2, and HDL3 levels with concomitant increase of cholesteryl ester transfer protein (CETP) activity by probucol in type II hyperlipoproteinemia. Artery: 20, 1-18, 1993
13. Homma Y, Kobayashi T, Yamaguchi H, Ozawa H, Sakane H, and Nakamura H: Specific reduction of plasma large, light low-density lipoprotein by a bile acid sequestering resin, cholebine (MCI-196) in type II hyperlipoproteinemia. Atherosclerosis in press.
14. Ikeda Y, Takagi A, Ohhara Y, Nogi K, Iwanaga T, Kurooka S, and Yamamoto A: A sandwich-enzyme immunoassay for the quantification of lipoprotein lipase and hepatic triglyceride lipase in post-heparin plasma using monoclonal antibodies to the corresponding enzymes. J. Lipid Red., 31 : 1991-1924, 1990
15. Instruction manual for Tint Elize® Lp (a), Umea, Sweden, Biopool AB.
16. Kataoka S, Paichi N, and Howard BV: Simplified isoelectric focusing, immunoblotting determination of apoprotein E phenotype. Clin. Chem., 40: 11-13, 1994
17. Kesäniemi YA, Ehnholm C, and Miettinen TA: Intestinal cholesterol absorption efficiency in man is related to apoprotein E phenotype. J. Clin. Invest, 80: 578-581, 1987
18. Mahley RW and Rail SC: Type III hyperlipoproteinemia (dysbetalipoproteinemia) the role of apolipoprotein E in normal and abnormal lipoprotein metabolism. In The Metabolic and Molecular Bases of Inherited Disease (eds: Scriver CR, Beaudet AL, Sly WS, and Valle D). New York, McGraw-Hill, 1995, 1953-1980 pp.
19. Musliner TA, Herbert PN, and Kingston MJ: Lipoprotein substrates of lipoprotein lipase and hepatic triglycerol lipase from human post-heparin plasma. Biophys. Biochem. Acta, 575: 277-288, 1979
20. Nagasaki T, and Akanuma Y: A new colorimetric method for the determination of plasma lecitin:cholesterol acyltransferase activity. Clin. Chum. Acta, 75: 372-375, 1977
21. Nishiwaki M, Ishikawa T, Homma Y, Tada N, Kagami A, Ohshima K, Ito T, Tomiyasu K, Shige H, Miyajima E, and Nakamura H: Effects of pravastatin on plasma lipids, apolipoproteins, Lp (a), remnant-like particle, cholesteryl ester transfer protein, and lecitin:cholesterol acyltransferase, a 12-month study. Nutr. Metab. Cardiovascul. Dis., 4 : 10-15, 1994
22. Noma A, Hata Y, and Goto Y: Quantification of serum apolipoprotein A-I, A-II, B, C-II, C-III, and E in healthy Japanese by turbidimetric immunoassay: reference values and age-and sex-related differences. Clin. Clim, Acta, 199 : 147-158, 1991
23. Ranganathan S, Hattori H, and Kashyap ML: A rapid flow cytometric assay for low-density lipoprotein receptors in human peripheral blood mononuclear cells. J. Lab. Clin. Med., 125. 479-481, 1995
24. Tall AR: Plasma high density lipoproteins. Metabolism and relationship to atherogenesis. J. Clin. Invest., 86: 379-384, 1990